Cargando…

Antibody induction after combined application of an adjuvanted recombinant FeLV vaccine and a multivalent modified live virus vaccine with a chlamydial component

The compatibility, safety and interaction on antibody induction of a combined vaccine application were assessed. Specific pathogen-free cats were vaccinated with either a modified live virus vaccine containing feline calici- (FCV), herpes- (FHV-1), parvovirus (FPV) and Chlamydophila felis (C. felis)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brunner, Chantal, Kanellos, Theo, Meli, Marina L., Sutton, David J., Gisler, Ricarda, Gomes-Keller, Maria Alice, Hofmann-Lehmann, Regina, Lutz, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2006
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115673/ https://www.ncbi.nlm.nih.gov/pubmed/16343700 http://dx.doi.org/10.1016/j.vaccine.2005.10.030

Ejemplares similares

Exposure of cats to low doses of FeLV: seroconversion as the sole parameter of infection
por: Major, Andrea, et al.
Publicado: (2009)

Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection
por: Hofmann-Lehmann, R., et al.
Publicado: (1995)

Comparative efficacy of the Leucofeligen™ FeLV/RCP and Purevax™ RCP FeLV vaccines against infection with circulating feline Calicivirus
por: Almeras, T., et al.
Publicado: (2017)

Comparative Efficacy of Feline Leukemia Virus (FeLV) Inactivated Whole-Virus Vaccine and Canarypox Virus-Vectored Vaccine during Virulent FeLV Challenge and Immunosuppression
por: Patel, M., et al.
Publicado: (2015)

Acute monoblastic leukemia in a FeLV-positive cat
por: Prihirunkit, Kreangsak, et al.
Publicado: (2008)

Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform—Analysis of Production and Immunogenicity
por: Ortiz, Raquel, et al.
Publicado: (2023)

The Diagnosis of Feline Leukaemia Virus (FeLV) Infection in Owned and Group-Housed Rescue Cats in Australia
por: Westman, Mark, et al.
Publicado: (2019)

Regulation of FeLV-945 by c-Myb binding and CBP recruitment to the LTR
por: Finstad, Samantha L, et al.
Publicado: (2004)

Diseases associated with spontaneous feline leukemia virus (FeLV) infection in cats
por: Reinacher, M.
Publicado: (1989)

Comparative measurement of FeLV load in hemolymphatic tissues of cats with hematologic cytopenias
por: Abdollahi-Pirbazari, Mehdi, et al.
Publicado: (2019)

Could Phylogenetic Analysis Be Used for Feline Leukemia Virus (FeLV) Classification?
por: Cano-Ortiz, Lucía, et al.
Publicado: (2022)

Molecular characterization of Brazilian FeLV strains in São Luis, Maranhão Brazil
por: Martins, Nathálya dos Santos, et al.
Publicado: (2023)

Difficulties in demonstrating long term immunity in FeLV vaccinated cats due to increasing age-related resistance to infection
por: Wilson, Stephen, et al.
Publicado: (2012)

Development of antibodies to feline IFN-γ as tools to elucidate the cellular immune responses to FeLV
por: Graham, Elizabeth M., et al.
Publicado: (2003)

Viral Determinants of FeLV Infection and Pathogenesis: Lessons Learned from Analysis of a Natural Cohort
por: Bolin, Lisa L., et al.
Publicado: (2011)

High prevalence of non-productive FeLV infection in necropsied cats and significant association with pathological findings
por: Suntz, M., et al.
Publicado: (2010)

Segregation of RD-114 and FeLV-related sequences in crosses between domestic cat and leopard cat
por: BENVENISTE, RAOUL E., et al.
Publicado: (1975)

Complete Genome Sequence of Feline Leukemia Virus Kawakami-Theilen Strain KT-FeLV-UCD-1
por: Chin, Pei-Ju, et al.
Publicado: (2020)

Clinicopathological findings of FeLV- positive cats at a secondary referral center in Florida, USA (2008–2019)
por: Pare, Amelie, et al.
Publicado: (2022)

Novel approach of dermatophytosis eradication in shelters: effect of Pythium oligandrum on Microsporum canis in FIV or FeLV positive cats
por: Načeradská, Martina, et al.
Publicado: (2021)

Follow-Up of Viral Parameters in FeLV- or FIV-Naturally Infected Cats Treated Orally with Low Doses of Human Interferon Alpha
por: Gomez-Lucia, Esperanza, et al.
Publicado: (2019)

First description of a multisystemic and lethal SARS-CoV-2 variant of concern P.1 (Gamma) infection in a FeLV-positive cat
por: Carneiro, Rodrigo Lima, et al.
Publicado: (2022)

Antigen-Sparing and Enhanced Efficacy of Multivalent Vaccines Adjuvanted with Immunopotentiators in Chickens
por: Wu, Peipei, et al.
Publicado: (2017)

Development of a multivalent adjuvanted inactivated vaccine against variant arthrotropic avian reoviruses
por: Ayalew, Lisanework E., et al.
Publicado: (2023)

Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components
por: Hernandez-Davies, Jenny E., et al.
Publicado: (2021)

Erratum: Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components
Publicado: (2021)

cGAMP-adjuvanted multivalent influenza mRNA vaccines induce broadly protective immunity through cutaneous vaccination in mice
por: Zhu, Wandi, et al.
Publicado: (2022)

A modular and self-adjuvanted multivalent vaccine platform based on porcine circovirus virus-like nanoparticles
por: Liu, Ze-Hui, et al.
Publicado: (2022)

Using Multivalent Adenoviral Vectors for HIV Vaccination
por: Gu, Linlin, et al.
Publicado: (2013)

Towards a safe and effective chlamydial vaccine: Lessons from the eye
por: Mabey, David C.W., et al.
Publicado: (2014)

Antibody and Cytokine Responses of Koalas (Phascolarctos cinereus) Vaccinated with Recombinant Chlamydial Major Outer Membrane Protein (MOMP) with Two Different Adjuvants
por: Khan, Shahneaz Ali, et al.
Publicado: (2016)

Efficacy of an Adenoviral Vectored Multivalent Centralized Influenza Vaccine
por: Lingel, Amy, et al.
Publicado: (2017)

Multivalent Fusion DNA Vaccine against Brucella abortus
por: Gómez, Leonardo, et al.
Publicado: (2017)

A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates
por: Kari, Laszlo, et al.
Publicado: (2011)

Capturing Complex Vaccine-Immune-Disease Relationships for Free-Ranging Koalas: Higher Chlamydial Loads Are Associated With Less IL17 Expression and More Chlamydial Disease
por: Lizárraga, David, et al.
Publicado: (2020)

The Koala Immune Response to Chlamydial Infection and Vaccine Development—Advancing Our Immunological Understanding
por: Quigley, Bonnie L, et al.
Publicado: (2021)

Structure-based design of chimeric antigens for multivalent protein vaccines
por: Hollingshead, S., et al.
Publicado: (2018)

Assessment of Antibodies Induced by Multivalent Transmission-Blocking Malaria Vaccines
por: Menon, Vinay, et al.
Publicado: (2018)

In silico Design of a Multivalent Vaccine Against Candida albicans
por: Tarang, Shikha, et al.
Publicado: (2020)

A multivalent T-antigen-based vaccine for Group A Streptococcus
por: Loh, Jacelyn M. S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5hs6a82v2t7l52htipnmhd9og8